Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015593
Filing Date
2020-08-14
Accepted
2020-08-13 18:42:47
Documents
65
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1006696
2 ex31-1.htm EX-31.1 20924
3 ex31-2.htm EX-31.2 20515
4 ex32-1.htm EX-32.1 6063
5 ex32-2.htm EX-32.2 5724
  Complete submission text file 0001493152-20-015593.txt   5335244

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE matn-20200630.xml EX-101.INS 858165
7 XBRL SCHEMA FILE matn-20200630.xsd EX-101.SCH 68236
8 XBRL CALCULATION FILE matn-20200630_cal.xml EX-101.CAL 49965
9 XBRL DEFINITION FILE matn-20200630_def.xml EX-101.DEF 297581
10 XBRL LABEL FILE matn-20200630_lab.xml EX-101.LAB 422899
11 XBRL PRESENTATION FILE matn-20200630_pre.xml EX-101.PRE 352617
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 201100684
SIC: 2834 Pharmaceutical Preparations